The report indicates that the market for drug of abuse testing will be growing at a healthy pace for the next few years, to reach $9.1 billion by 2023. Some of the factors driving the growth of the global drug of abuse testing market include increased use of drug of abuse testing at organizational levels and increased production and trade of illicit drugs.
Explore report sample at: https://www.psmarketresearch.com/market-analysis/drug-of-abuse-testing/report-sample
The use of drug of abuse testing is increasing at the organizational level to increase productivity, improve safety, and reduce absenteeism. According to the SAMHSA, in 2015, maximum use of illicit drugs was found in the hospitality and food services industry, and approximately 19.1% of full-time workers aged 18 years to 64 years were reported to have used illicit drugs in a span of 30 days, during 2008 to 2012 in the U.S. According to the same survey, in the U.S. maximum alcohol abuse was found in the mining industry, approximately 17.5% of full-time workers aged 18 to 64 years, were reported to have done heavy alcohol drinking in a span of 30 days. Due to rising use of illicit drugs, there has been an increased utilization of drug of abuse testing at the organizational level, which is expected to drive the growth of the market in the future.
Geographically, the European drug of abuse testing market is expected to be the second largest by 2023, mainly due to increased trade and consumption of illicit drugs, and rising compliance of organizations with respect to workplace drug of abuse testing. The prevalence of drug utilization depends upon drug policies, availability of drug, and nearness to the source of drug trade. According to the Crime Survey for England and Wales (CSEW), the consumption of illicit drugs was estimated to be 8.1% in 2012-2013. and in 2013-2014, approximately 8.8% of the total population of Europe (aged 16 to 59 years) consumed illicit drugs.
Explore report overview with detailed TOC on “Drug of Abuse Testing Market” at: https://www.psmarketresearch.com/market-analysis/drug-of-abuse-testing
Siemens AG, Merck KGaA, Alere Inc., Bio-Rad Laboratories, and ThermoFisher Scientific Inc. are some of the major players that offer drug of abuse testing products. In terms of product offerings, Siemens AG is the leading player in the global market and provides various instruments for drug of abuse testing in approximately 150 countries. Immunoassay analyzers are offered by a large number of players such as Siemens AG, Merck KGaA, bioMérieux S.A., Roche Holding AG, Alere Inc., Abbott Laboratories, Randox Laboratories Ltd., Bio-Rad Laboratories, and Thermo Fisher Scientific Inc. Breath analyzers, on the other hand, are offered by few players, such as Siemens AG and Drägerwerk AG & Co. KGAA.
Source: P&S Intelligence